Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolasetron Efficacy in Fibromyalgia
NCT00820326Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Mar 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolasetron in fibromyalgia (FM), sponsored by CHU de Limoges. Started Mar 2004; status: completed.
02
Drugs
dolasetron
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00820326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820326.